Basel Medical (BMGL) Liabilities and Shareholders Equity (2024 - 2025)
Basel Medical (BMGL) posted Liabilities and Shareholders Equity of $15.5 million for Q4 2025, up 8.2% sequentially from $14.4 million in Q2 2025, and up 3.98% YoY from $14.9 million in Q4 2024.
Powered by 
Analysis
Basel Medical (BMGL) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends
Basel Medical has reported Liabilities and Shareholders Equity for 2 years, with the latest figure at $15.5 million in Q4 2025.
- Quarterly Liabilities and Shareholders Equity rose 3.98% year-over-year to $15.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $56.9 million (changed N/A YoY) and the FY2025 annual result came in at $14.1 million, up 16.96% from the prior year.
- Liabilities and Shareholders Equity advanced to $15.5 million in Q4 2025 per BMGL's latest filing, from $14.4 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $15.5 million in Q4 2025 and troughed at $12.1 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 89.80 Bn | 88.78 Bn | 15.19 Bn | 63.25 Bn |
| 2 | Tenet Healthcare | 22.14 Bn | 19.97 Bn | 4.45 Bn | 30.68 Bn |
| 3 | Encompass Health | 12.08 Bn | 11.94 Bn | 1.34 Bn | 7.46 Bn |
| 4 | Davita | 11.83 Bn | 11.14 Bn | 1.16 Bn | 17.71 Bn |
| 5 | Universal Health Services | 10.14 Bn | 10.00 Bn | 3.29 Bn | 15.94 Bn |
| 6 | Ensign | 9.91 Bn | 9.59 Bn | 306.24 Mn | 5.75 Bn |
| 7 | Chemed | 6.89 Bn | 6.85 Bn | 221.47 Mn | 1.58 Bn |
| 8 | Pacs | 6.74 Bn | 6.57 Bn | 338.46 Mn | 5.66 Bn |
| 9 | Concentra Group Holdings Parent | 4.31 Bn | 4.15 Bn | 192.10 Mn | 3.01 Bn |
| 10 | Basel Medical | 7.33 Mn | 6.54 Mn | - | 15.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15.53 Mn |
| Jun 30, 2025 | 14.35 Mn |
| Dec 31, 2024 | 14.93 Mn |
| Jun 30, 2024 | 12.05 Mn |